Drug Trial Radar · NCT00003634
Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy
Last checked: Nov 19, 2026Latest source record: Nov 6, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
400
Planned (sponsor's estimate)
Start
Apr 1998
Primary completion
Not stated
Sponsor
- Lead sponsor
- AltaRexIndustry
- Sponsor type
- Industry
- First posted
- Sep 13, 2004
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Primary purpose
- Treatment
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
RATIONALE: Monoclonal antibodies can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. It is not yet known whether giving monoclonal antibody therapy is more effective than a placebo in treating patients with ovarian epithelial, fallopian tube, or peritoneal cancer who have responded to surgery and chemotherapy. PURPOSE: Randomized phase II trial to study the effectiveness of monoclonal antibody therapy in treating patients with residual disease from stage III or stage IV ovarian epithelial, fallopian tube, or peritoneal cancer following surgery and chemotherapy.
Conditions
- Fallopian Tube Cancer
- Ovarian Cancer
- Primary Peritoneal Cavity Cancer
Interventions
oregovomabBiological
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
46 sites in 2 countries. Site status is shown where the registry gives one.
Alta Bates Comprehensive Cancer Center
Berkeley, California
USC/Norris Comprehensive Cancer Center
Los Angeles, California
Jonsson Comprehensive Cancer Center, UCLA
Los Angeles, California
Chao Family Comprehensive Cancer Center
Orange, California
Wilshire Oncology Medical Center
Pomona, California
Stanford University School of Medicine
Stanford, California
University of Colorado Cancer Center
Denver, Colorado
Patty Berg Cancer Center
Fort Myers, Florida
University of Florida Health Science Center - Jacksonville
Jacksonville, Florida
Walt Disney Memorial Cancer Institute
Orlando, Florida
University of Chicago Cancer Research Center
Chicago, Illinois
Saint Mary's Hospital
East Saint Louis, Illinois
Lutheran General Cancer Care Center
Park Ridge, Illinois
University of Iowa Hospitals and Clinics
Iowa City, Iowa
Alton Ochsner Medical Foundation Hospital
New Orleans, Louisiana
Marlene & Stewart Greenebaum Cancer Center, University of Maryland
Baltimore, Maryland
New England Medical Center Hospital
Boston, Massachusetts
Henry Ford Hospital
Detroit, Michigan
University of Minnesota Medical School
Minneapolis, Minnesota
Ellis Fischel Cancer Center
Columbia, Missouri
North Shore University Hospital
Manhasset, New York
State University of New York - Upstate Medical University
Syracuse, New York
University of Oklahoma
Oklahoma City, Oklahoma
Spartanburg Regional Medical Center
Spartanburg, South Carolina
Baptist Regional Cancer Center - Knoxville
Knoxville, Tennessee
University of Texas Southwestern Medical School
Dallas, Texas
U.S. Oncology
Houston, Texas
Cancer Center, University of Virginia HSC
Charlottesville, Virginia
Swedish Hospital Tumor Institute
Seattle, Washington
Tom Baker Cancer Center - Calgary
Calgary, Alberta, Canada
Cross Cancer Institute
Edmonton, Alberta, Canada
British Columbia Cancer Agency - Fraser Valley Cancer Centre
Surrey, British Columbia, Canada
British Columbia Cancer Agency
Vancouver, British Columbia, Canada
Manitoba Cancer Treatment and Research Foundation
Winnipeg, Manitoba, Canada
Saint John Regional Hospital
Saint John, New Brunswick, Canada
Nova Scotia Cancer Centre
Halifax, Nova Scotia, Canada
Northeastern Ontario Regional Cancer Centre, Sudbury
Greater Sudbury, Ontario, Canada
Cancer Care Ontario-Hamilton Regional Cancer Centre
Hamilton, Ontario, Canada
Cancer Care Ontario-London Regional Cancer Centre
London, Ontario, Canada
Credit Valley Hospital
Mississauga, Ontario, Canada
Showing 40 of 46 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.